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Abstract
Background: We present here an extensive epigenetic analysis of a 500 kb region, which encompasses
the human desmin gene (DES) and its 5' locus control region (LCR), the only muscle-specific transcriptional
regulatory element of this type described to date. These data complement and extend Encyclopaedia of
DNA Elements (ENCODE) studies on region ENr133. We analysed histone modifications and underlying
DNA methylation patterns in physiologically relevant DES  expressing (myoblast/myotube) and non-
expressing (peripheral blood mononuclear) primary human cells.
Results: We found that in expressing myoblast/myotube but not peripheral blood mononuclear cell
(PBMC) cultures, histone H4 acetylation displays a broadly distributed enrichment across a gene rich 200
kb region whereas H3 acetylation localizes at the transcriptional start site (TSS) of genes. We show that
the DES LCR and TSS of DES are enriched with hyperacetylated domains of acetylated histone H3, with
H3 lysine 4 di- and tri-methylation (H3K4me2 and me3) exhibiting a different distribution pattern across
this locus. The CpG island that extends into the first intron of DES is methylation-free regardless of the
gene's expression status and in non-expressing PBMCs is marked with histone H3 lysine 27 tri-methylation
(H3K27me3).
Conclusion: Overall, our results constitute the first study correlating patterns of histone modifications
and underlying DNA methylation of a muscle-specific LCR and its associated downstream gene region
whilst additionally placing this within a much broader genomic context. Our results clearly show that there
are distinct patterns of histone H3 and H4 acetylation and H3 methylation at the DES LCR, promoter and
intragenic region. In addition, the presence of H3K27me3 at the DES methylation-free CpG only in non-
expressing PBMCs may serve to silence this gene in non-muscle tissues. Generally, our work demonstrates
the importance of using multiple, physiologically relevant tissue types that represent different expressing/
non-expressing states when investigating epigenetic marks and that underlying DNA methylation status
should be correlated with histone modification patterns when studying chromatin structure.
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Background
Epigenetic modifications that affect gene expression
include post-translational modifications on N-terminal
tails of histones and DNA methylation. Detailed analysis
of epigenetic status can provide insight into the location
and function of genetic regulatory elements on a genome-
wide basis. A major challenge in the post-genomic era is
the mapping and functional characterization of the full
complement of transcriptional regulatory elements
including promoters, enhancers, locus control regions
(LCRs) and chromatin domain boundary elements. As a
first step in meeting this objective, the Encyclopaedia Of
DNA Elements (ENCODE) project was launched, which
aims to map the complete set of genetic control elements
within selected regions amounting to 1% (~30 Mb) of the
human genome [1-4].
The human desmin gene (DES) locus (ch2q35) is covered
in part within one of the ENCODE regions designated as
ENr331, which was chosen due to its high gene density
and high non-exonic sequence conservation. ENr331 cov-
ers approximately 500 kb of chromosome 2q35 (hg 17 co-
ordinates chr2:220,102,851–220,602,850; assembly May
2004) and includes DES and the downstream genes but
excludes its locus control region (LCR) [5,6]. The DES
LCR is the only muscle-specific transcriptional regulatory
element of this type described to date and constitutes a
highly evolutionarily conserved element located between
9–18 kb 5' of DES that has been shown to drive reproduc-
ible, full physiological levels of expression in all muscle
cell types [5,6]. As in the case of β-globin gene clusters [7],
the DES LCR may co-ordinate expression of some or all of
the downstream muscle-specific genes within this region
namely DES, APEG1, SPEG and CHPF. This type of gene/
regulatory element configuration has been referred to as a
functional gene domain [8,9]. The 5' end of DES is also
associated with a small compact methylation-free CpG
island [10] that spans the first exon, a common feature for
approximately 40% of tissue specifically expressed genes
[11].
Several post-translational histone modifications have
now been identified which affect regulation of gene
expression such as lysine acetylation/methylation and
phosphorylation on serine residues [12]. With advances
in detection methods for these modifications, subtle dif-
ferences between varying histone marks have been
described. For example, histone H3 and H4 acetylation
demonstrate a slightly different pattern throughout the
GH1 [growth hormone GH-N, 13] and the HBB_CHICK
[14,15] gene clusters both of which contain LCR ele-
ments. Enhancers and other types of transcriptional regu-
latory elements can be predicted through a determination
of their histone modification pattern, which appears dis-
tinct from that observed at promoter or TSS regions. It is
now clear that certain histone patterns are highly predic-
tive of the transcriptional state of DNA [3,4].
Eukaryotic DNA can be methylated at the cytosine of a
CpG dinucleotide, which generally has a repressive effect
on transcription [16]. There is strong evidence to suggest
a link between DNA methylation status and certain
repressive histone modification marks [17-19] particu-
larly methylation of histone H3 at lysine 9 (H3K9) and 27
(H3K27), which are important modifications for gene
repression [20]. Furthermore, tri-methylation of histone
tail H3 lysine (K) 27 (H3K27me3) [21], has been shown
to preferentially mark unmethylated DNA in early devel-
opment and cause silencing by recruiting repressive Poly-
comb group (PcG) complexes [18].
We have therefore undertaken an analysis of both DNA
methylation and histone modifications to gain greater
insight into the types of epigenetic marks that are func-
tionally correlated with the DES locus and especially at
the DES LCR. As the epigenome will vary between differ-
ent tissues displaying different gene expression profiles, it
is important to conduct such epigenetic investigations in
an appropriate range of cell types that will represent
expressing and non-expressing states for a genomic region
of interest. Recent work has addressed this issue to some
extent [4] but here we strive to give a more detailed and
focused analysis of a well characterized gene locus in pri-
mary human cells which are more physiologically rele-
vant.
We have employed a wide range of techniques to substan-
tially extend the epigenetic analysis of ENr331 in primary
muscle and non-muscle human cell types to provide
insight into which types of histone modifications can co-
exist at a given locus with a corresponding underlying
DNA methylation pattern. Our results show that in
expressing skeletal myoblast/myotube cultures generally
histone H4 acetylation is broadly distributed across a gene
rich 200 kb region of chromosome 2q35 encompassed
within ENr331 extended to include the DES LCR whereas
H3 acetylation localizes at the TSS of genes. More specifi-
cally, the DES LCR and first exon are enriched with hyper-
acetylated domains of histone H3 and that H3K4 me2 and
me3 exhibit a different distribution pattern across this
locus. In addition, CpG methylation combined with his-
tone mapping identified one of the DNaseI hypersensitive
site (HS) elements that constitute the DES  LCR as of
potential critical functional importance. We found the
CpG island spanning the DES promoter to be unmethyl-
ated regardless of expression status and to be marked with
H3K27me3 in PBMCs, which may serve a promoter
silencing role in non-muscle cells.BMC Molecular Biology 2009, 10:51 http://www.biomedcentral.com/1471-2199/10/51
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Results
ChIP-on-chip: global H3 and H4 histone acetylation 
patterns across 500 kb of chromosome 2q35 encompassing 
the DES locus
The DES  locus contains three muscle specific/preferen-
tially expressed genes, DES APEG1 and SPEG, which are
flanked by two housekeeping genes DNPEP and GMPPA.
This region also includes the DES LCR which lies 9–18 kb
5' of DES and which is composed of 5 muscle-specific
DNaseI HS numbered 1–5 in a 3' to 5' direction [6]. Anal-
ysis of the DNA sequence that underlies the elements of
the  DES  LCR shows sub-regions of high (83–100%)
sequence conservation between rodents (mouse/rat) and
humans within or near each HS site designated with the
letters a, b, c or d [6]. Expression of DES increases upon
fusion of unfused (UF) skeletal myoblasts to fused (F)
myotubes [22] (see Additional file 1, Figures S1 and S2).
The ENCODE region ENr331 which spans 500 kb of chro-
mosome 2q35 does not include the DES LCR as it termi-
nates -5.7 kb 5' of DES. However, ENr331 does span DES
and the more downstream genes SPEG, GMPPA, ACCN4,
CHPF, INHA, SLC4A3 (Figure 1). A small spotted micro-
array consisting of ~500 bp overlapping PCR products was
designed to extend the area covered by ENr331 to encom-
pass the DES LCR (-18 kb to -8.3 kb 5' of the DES TSS).
Note: the PCR primers used to extend the region of the
array are shown in Additional file 1, Table ST1.
Native chromatin without cross-linking, with a size range
of mono-tetranucleosomes was isolated from cultures of
human primary myoblasts, myotubes and PBMCs and
subjected to immunoprecipitation with antibodies
against histones H3 and H4 acetylated at multiple lysine
residues, namely lysines 9 and 14 on H3 and lysines 5, 8,
12 and 16 on H4, which have been associated with a tran-
scriptionally competent chromatin state [23,24]. This
allowed a complete analysis of the histone H3 and H4
acetylation pattern of this entire area in unfused (UF)
myoblasts, fused (F) myotubes and PBMCs (Figure 1).
The peaks of enrichment of H3 lysine acetylation through-
out the region analysed corresponded to the TSS of most
of the genes including DES (Figure 1A). The DES LCR was
enriched for H3 acetylation approximately 2–5 fold above
non-muscle PBMCs in both myoblasts and myotubes
(Figure 1A and Additional file 1, Figure S3).
In contrast to H3 acetylation, which exhibits a relatively
tight peak of enrichment localized to the DES promoter,
H4 acetylation displays abundance across the entire tran-
scribed region of DES (Figure 1B; panels UF and F) and
extends into intergenic areas. This was also the case with
other individual genes within the region such as CHPF,
which exhibited a broad enrichment across its entire gene
body (Figure 1B and Additional file 1, Figure S3). A ~5-
fold enrichment of H4 acetylation was observed at the
DES LCR and promoter compared with PBMCs (Figure 1B
and Additional file 1, Figure S3). Similarly to H3 acetyla-
tion, there was very little enrichment of histone H4
acetylation in PBMCs across the area analysed (Figure 1;
panels PBMC). See Additional data file 1, Figure S3 and
S3' for detailed analysis of individual genes with the
region.
The current genome browser build hg18 only illustrates
SPEG. However it must be noted that APEG1 is one of its
isomers and is transcribed from an internal separate pro-
moter [6]. The presence of the internal (APEG1) promoter
accounts for the presence of a peak of acetylation seen on
the microarray at this position (Figure 1 and Additional
file 1, Figure S3).
DES and the DES LCR show high levels of tissue-specific 
but a selective histone modification pattern
Having obtained a general overview of histone H3 and H4
acetylation patterns across the DES locus and surrounding
500 kb region, we next sought to obtain a more detailed
map of epigenetic status specifically across the DES LCR,
as this constitutes a crucial regulatory element. Chromatin
used for the microarray analysis was analysed by Q-PCR
to assess enrichment for selected regions within DES and
the DES LCR.
Histone H3 and H4 acetylation showed a marked enrich-
ment of between 5 to 15-fold above PBMC levels in both
myoblasts and myotubes at all of the positions tested
within the DES LCR (Figure 2A and 2B; amplicons A-E).
Element HS3c exhibited the highest overall level of his-
tone acetylation within the LCR in both myoblasts and
myotubes reaching levels of ~15-fold enrichment (Figure
2A and 2B; amplicon C). We also observed enrichment of
H3 acetylation across the DES TSS (Figure 2A; amplicons
G-J) but with the highest level present 3' of the first exon
at position +0.8 kb (Figure 2A; amplicon I). This level of
enrichment decreased by almost 2-fold at the second exon
(Figure 2A; amplicon J). Histone H4 acetylation was
enriched at similar levels (~10–15 fold) across parts of the
LCR and DES (Figure 2B; amplicons C-E and G-J).
PBMCs did not show any enrichment of histone H3 and
H4 acetylation across either DES or its LCR reflecting these
elements muscle-specific nature and function (Figure 2A
and 2B, amplicons A-J). The only enrichment of both his-
tone H3 and H4 acetylation in the PBMC sample was seen
at the TSS of DNPEP and HTATIP2, which is as expected
for ubiquitously expressed genes (Figure 2A and 2B;
amplicons DNPEP and HTATIP2). We also investigated
the chromatin structure between HS1 of the LCR and the
DES TSS, a region at a position approximately -4 kb 5' ofBMC Molecular Biology 2009, 10:51 http://www.biomedcentral.com/1471-2199/10/51
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Microarray analysis for histone H3 and H4 acetylation across the DES LCR and ENCODE region ENr331 covering 500 kb of  human chromosome 2q35 Figure 1
Microarray analysis for histone H3 and H4 acetylation across the DES LCR and ENCODE region ENr331 cov-
ering 500 kb of human chromosome 2q35. Chromatin (mono-tetranucleosomes) prepared using the nChIP approach was 
hybridized to a microarray tile, which covers a 500 kb region of chromosome 2q35 and encompasses the DES LCR and DES. 
Annotated genes taken from the UCSC genome browser http://genome.ucsc.edu are shown as black rectangles in each panel. 
(A) A peak of histone H3 acetylation can be observed at the beginning of the genes DES, SPEG and ACCN4. Note the grey bar 
indicating the position of APEG1. (B) Histone H4 acetylation appears over the entire gene rich region and is highly enriched 
across the DES promoter and LCR in muscle cells. The solitary peak of H4 acetylation downstream of the gene rich region 
(Panel F) was caused by an excess of Cy3 dye background staining on the corresponding part of the slide and therefore does 
not represent a true enrichment. Fold enrichment was obtained from an average ratio of two independent experiments.BMC Molecular Biology 2009, 10:51 http://www.biomedcentral.com/1471-2199/10/51
Page 5 of 12
(page number not for citation purposes)
DES  and found no enrichment of histone H3 or H4
acetylation in any of the samples (Figure 2A and 2B;
amplicon F).
The microarray data correlates well with the higher resolu-
tion native ChIP (nChIP) results both showing similar
trends in H3 and H4 acetylation. However, the Q-PCR
and microarray sets of data are technically very different
and therefore quantitative comparisons between the two
are not possible.
Histone H3K4me2 marks the DES LCR
Histone methylation patterns have been shown to mark
different regions of a transcribing gene and to distinguish
between promoters and distal enhancers [3,25]. We there-
fore assessed the presence of histone H3K4me2 and
H3K4me3 at the same regions analysed for global H3 and
H4 histone acetylation (Figure 2A and 2B). This also
allowed the correlation between histone acetylation and
methylation to be examined. H3K4me2 displayed a wide-
spread distribution across the region being enriched up to
20-fold above background levels at elements HS4d to HS1
within the DES  LCR (Figure 2C; amplicons B-E). The
unfused myoblasts exhibited a 20-fold enrichment across
the first 2 kb of DES (Figure 2C; amplicons G-J) whereas
myotube cultures showed the same level of enrichment
but had a high peak of ~40-fold of H3K4me2 at the end
of exon 1 of DES (Figure 2C; amplicon I). PBMCs did not
show any enrichment across the DES LCR or DES but
showed a marked abundance of ~25-fold above back-
ground of H3K4me2 at the control housekeeping gene
promoter of HTATIP2 as expected from previous work
[26].
H3K4me3 was not enriched at any site within the DES
LCR within any of the cell types tested (Figure 2D; ampli-
cons A-E). However, there was a ~40-fold enrichment of
this mark above background levels before the start of the
second exon of DES  in both myoblasts and myotubes
(Figure 2D; amplicons H-J). This decreased sharply in the
myoblast sample by the second exon compared to that
observed in the myotube culture, which remained high at
this position (Figure 2D; amplicon J).
DNA methylation status of CpG sites within DES and DES 
LCR
DES is approximately 8.3 kb in length with 9 exons and is
associated with a small compact CpG island of 550 bp
that spans its first exon and has a CpG count of 74, a CpG
percentage of 27.0% and a ratio of observed to expected
CpG dinucleotides of 1.08. Due to the tissue-specific
expressed nature of this gene we were able to correlate the
histone modification patterns we observed within DES
and the DES LCR with the underlying DNA methylation
pattern in different transcriptionally active and inactive
states. DNA methylation was analysed using sodium
bisulphite conversion coupled with PCR/sequencing in
adult human primary myoblasts, myotubes and PBMCs at
CpG rich areas throughout the LCR and DES (Figure 3;
amplicons I-VII) and which corresponded to regions of
high sequence conservation between rodents (mouse/rat)
and human [6].
Regions analysed within the DES LCR included HS5 and
HS4d (Figure 3; amplicons I and II). The two CpG sites
within HS5 within the region of rodent/human homology
were fully methylated in all the cell types analysed (Figure
3B; panel I). HS4d contained 3 CpG dinucleotides all of
which were unmethylated in the myotubes (Figure 3B;
panel II, F), showed a mixed pattern of methylation in
myoblasts (Figure 3B; panel II, UF) but were ~96% meth-
ylated in PBMCs (Figure 3B; panel II, PBMCs).
Within element HS3 only sub-regions HS3c and HS3b
were analysed, as HS3a does not contain any CpG dinu-
cleotides. All the CpG sites within HS3c and b in the
unfused myoblasts were unmethylated (Figure 3, panel III
and IV; UF). Within HS3b in the myotubes the majority of
the CpG sites were unmethylated apart from 1 out of the
total of 5 CpG sites analysed, which exhibited 90% meth-
ylation (Figure 3B, panel IV; F). All the CpG sites except
for one within HS3c showed a high percentage of methyl-
ation (~40–100%) in PBMCs (Figure 3B, panel III and IV;
PBMC) demonstrating that this region is highly methyl-
ated compared to muscle cells.
The DES TSS genomic region was analysed to determine
where the region of transition occurs between unmethyl-
ated and methylated DNA in both a 5' and 3' direction
(Figure 3). The 10 CpG sites within the +0.7 kb-+1.5 kb
region exhibit a mixed pattern of methylation in both
muscle and non-muscle cell types (Figure 3B; panel VII),
which indicates that the methylation-free CpG area of
DNA appears to end +0.7 kb 3' of the DES TSS. Analysis of
a region ~0.5 kb upstream of the DES TSS at the start of the
CpG island, showed that all seven CpG sites in this area
lack methylation (Figure 3B; panel VI) in all cell types
including PBMCs. Therefore, this unmethylated DNA is
not related to the transcriptional status of DES. The extent
of the island is restricted to the GC dense region spanning
the first exon of DES (Figure 3A; CpG). These results also
demonstrate that the gene body of DES  is methylated
starting before the start of the second exon even in
expressing muscle cell types (Figure 3B; panel VII). Gene
body methylation has now been reported in several sys-
tems [27-30].BMC Molecular Biology 2009, 10:51 http://www.biomedcentral.com/1471-2199/10/51
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The unmethylated CpG island spanning the DES promoter 
is marked by H3K27me3 in PBMCs
DNA methylation analysis showed that the CpG island
spanning the DES promoter was unmethylated in both
muscle and non-muscle cell types (Figure 3). Given that
methylation-free CpG islands are usually associated with
an open chromatin structure this poses the question as to
how the DES promoter region is repressed in non-express-
ing cells? The absence of muscle specific transcription fac-
tors in non-muscle cells could be sufficient to prevent
transcription of DES in non-muscle cells. However, the
DES promoter does possess ubiquitous transcription fac-
tor binding sites such as Sp1 [31] that would be expected
to be functional and therefore suggesting that additional
Fine resolution mapping of histone modifications across the DES LCR and DES in myoblasts and myotubes compared to PBMCs Figure 2
Fine resolution mapping of histone modifications across the DES LCR and DES in myoblasts and myotubes 
compared to PBMCs. Chromatin was prepared from myoblasts, myotubes and PBMCs for nChIP (as Figure 1) and amplified 
using Q-PCR to gain a comprehensive picture of histone modifications status across the DES LCR and DES. (A) Histone H3 
acetylation in unfused myoblasts (UF, black bars), in fused myotubes, which express DES 2-fold higher than myoblasts (F, white 
bars) and in non-expressing PBMCs (grey bars) across DES and the DES LCR. (B) As panel (A) but showing the distribution of 
histone H4 acetylation. (C) Histone H3K4 di-methylation (H3K4me2) in unfused myoblasts (UF, black bars), in fused myotubes 
(F) and in non-expressing PBMCs (grey bars) across DES and the DES LCR. (D) As panel (C) but showing histone H3K4me3 
enrichment across DES and the DES LCR. Positive controls include the housekeeping genes DNPEP and HTATIP2 and as a non-
expressing negative control, HBB. (E) Illustration of DES and DES LCR genomic region. The black rectangles and horizontal 
arrow denote the exons and direction of transcription of DES respectively. Vertical arrows indicate the relative positions of 
the DES LCR HS and evolutionarily conserved regions. Vertical bars designated A-J denote the positions of the PCR amplicons 
following nChIP. Results are presented as fold-enrichment of IP samples over input DNA. Error bars represent the standard 
deviation about the mean fold-enrichment from at least 2 separate PCRs performed in duplicate from 2 independent nChIP 
experiments. Enrichment across the muscle-specific DES locus was above non-specific binding background controls (no anti-
body and IgG) in the myoblast/myotube cultures but not PBMCs. P value < 0.05 denoted by an asterisk (*).
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mechanisms may contribute to the complete silencing of
DES in non-muscle cells.
A possible candidate epigenetic mark for suppressing
expression from the DES promoter in non-muscle tissues
is H3K27me3, which has been implicated in marking
unmethylated DNA for silencing [18]. In addition, meth-
ylation of H3K27 has been universally linked to gene
repression [21,32-34] unlike H3K9 methylation which
has been found at both inactive and active genes
[12,35,36]. Therefore, we determined whether
H3K27me3 was present across the LCR and DES in non-
muscle PBMCs and muscle cells. The only region that was
found to be enriched by 9–15 fold for H3K27me3 above
background levels was across the DES unmethylated CpG
island in the PBMC sample (Figure 4; amplicons G-I). This
High-resolution DNA methylation mapping of individual CpG dinucleotides within highly conserved regions of the DES LCR Figure 3
High-resolution DNA methylation mapping of individual CpG dinucleotides within highly conserved regions of 
the DES LCR. Sodium bisulphite conversion of HindIII-digested human unfused myoblast (UF), fused myotube (F) and PBMC 
DNA followed by PCR amplification, cloning and sequencing was used to obtain a high-resolution map of the methylation sta-
tus across GC-rich regions of high sequence homology between mouse, rat and human within the DES LCR. (A) Top line: illus-
tration of the DES and DES LCR HS 1–5 and positions of the evolutionarily conserved elements (vertical arrows). Middle line: 
CpG density map. Each vertical line represents a single CpG dinucleotide residue. Bottom line: position of PCR amplicons fol-
lowing genomic DNA bisulphate conversion and nChIP (Figure 2). (B) Methylation status of individual CpG sites. Each line rep-
resents the result within independent clones of PCR amplified regions. Open/white circles indicate an unmethylated CpG site; 
closed/black circles, methylated CpG sites. At certain sites circles are missing, sequence data was not available for these indi-
vidual CpG sites. Amplicons used for nChIP analysis are shown (A-G) by a horizontal double-ended arrow. Positions of 
sequenced regions relative to the TSS of DES are indicated in kb. Regions of homology within the LCR are marked by a hori-
zontal grey line.
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peak of enrichment was tightly localized to the methyla-
tion-free CpG island and dropped to background levels by
the second exon of DES (Figure 4; amplicon J). No signif-
icant enrichment above background was seen in the
myoblast/myotube cultures (data not shown). Interest-
ingly, this mark was not seen at either the -4 kb region
between the LCR and the DES TSS or across the LCR in
PBMCs (Figure 4; A-E). In addition, H3K27me3 was not
observed at the CpG poor promoter of HBB that is also
silent in PBMCs (Figure 4A). These observations provide
strong support for the concept that H3K27me3 is a his-
tone modification that marks silent chromatin at specific
genomic locations [21].
Discussion
Our work constitutes the first detailed epigenetic investi-
gation of a muscle-specific LCR associated with DES. We
have conducted an extensive epigenetic analysis of 500 kb
of human chromosome 2q35, which includes the muscle-
specific  DES  locus and encompasses ENCODE region
ENr331. Our work expands on previous analysis of
ENr331 on several points. Firstly, the microarray tile was
extended to include the DES LCR, a crucial transcriptional
regulatory element in this genomic region. Secondly, we
have analysed the epigenetic status of ENr331 and espe-
cially the DES and DES LCR regions in human primary
skeletal muscle cells, both proliferating myoblasts and
post-mitotic differentiated myotubes as well as non-mus-
cle PBMCs. Therefore, unlike previous investigations of
this region we were able to compare epigenetic patterns in
physiologically relevant, expressing/non-expressing situa-
tions. Thirdly, we have correlated histone modification
patterns across the DES and DES LCR with the underlying
DNA methylation pattern, again in expressing and non-
expressing states of the locus.
Our results from microarray ChIP-on-chip studies show
that in myoblast/myotube cultures the DES  locus lies
within an extended hyperacetylated chromatin region that
was not present in non-muscle PBMCs (Figure 1) suggest-
ing a role of the muscle specific DES LCR in establishing
this active domain. The ChIP-on-chip results also high-
light differences in histone acetylation between gene rich
and gene poor areas over this 500 kb region.
High resolution nChIP coupled with Q-PCR was
employed to validate the microarray data and dissect the
histone modification patterns across the 5'region of DES
including its LCR. The analysis showed that histone H4
acetylation displayed similar levels of enrichment across
the LCR and the first 2 exons of DES in skeletal muscle
cells (Figure 2B). This is in contrast to H3 acetylation,
which was more abundant around the DES TSS than at the
LCR (Figure 2A). The peak of H3 acetylation over the DES
promoter and TSS may be accounted for by the presence
of MEF-2 and E-box elements within these regions [31].
MEF-2 and the myogenic factors are known to recruit his-
tone acetyltransferase (HAT) activity [37] and therefore
their binding and action at the DES  promoter and
enhancer elements could produce the peak of H3 acetyla-
tion that we observe at this region.
Interestingly, unfused myoblasts and fused myotubes dis-
played similar histone modification and DNA methyla-
tion patterns across the DES locus. This implies that an
open chromatin region already exists in unfused myob-
lasts although they exhibit a lower level of DES expres-
sion. Therefore, the histone acetylation seen in myoblasts
may have been established at an earlier time point before
myoblast differentiation. Consequently, the increase of
DES expression observed in myotubes could result from
an enhancement in transcription factor binding activity
rather than a change in overall chromatin architecture.
The only significant difference between myoblast and
myotube modification patterns that we observed was in
histone methylation at DES 3' of the first exon where in
fused myotubes the levels of H3K4me2 and me3 are 20–
30 fold higher than in the myoblasts (Figure 2C and 2D).
This implies an increase in the levels of histone methyl-
transferase (HMT) activity across DES coupled with an
increase of transcription.
DNA methylation analysis of the LCR showed that HS3
was unmethylated in skeletal muscle cells compared to
PBMCs whereas HS4 and HS5 both contained methylated
CpG sites even within the muscle cell samples (Figure 3).
Interestingly, the mapped HS5 site lies within an Alu
repeat element http://genome.ucsc.edu which is also GC
rich and may explain why this HS site is methylated. It has
also been shown that the density of CpG dinucleotides is
directly linked to their methylation state and that a low
density of methylated CpG sites does not perturb tran-
scription [28]. Therefore, in the case of HS5 which has a
relatively small number of CpG sites their methylation
status may not be relevant to its function.
Histone H3K27me3 has been correlated with inactive
genes [21,32]. Here we show that, H3K27me3 marks the
CpG island of DES only in non-expressing PBMCs (Figure
4) and this could constitute a mechanism by which the
DNA at the CpG island promoter of DES  remains
unmethylated but inactive in all cells types except muscle.
There are extensive genome wide studies on the histone
patterns across genes and regulatory elements
[3,21,32,34,38,39]. Our results are in concordance with
previous genome wide analysis in particular H3K4me3
preferentially marking the DES TSS and H3K4me2 being
more dominant at its regulatory element, the LCR. In
addition, our data appear to be typical for complex regu-
latory elements of this type [14,15,36]. However, genomeBMC Molecular Biology 2009, 10:51 http://www.biomedcentral.com/1471-2199/10/51
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wide studies in the cell types used would not have illus-
trated the histone modification pattern across the muscle-
specific  DES  locus, therefore our analysis shows the
importance of using the appropriate cell type when ana-
lysing a tissue specific locus.
Conclusion
Taken together these findings show that the DES  gene
cluster lies within a hyperacetylated transcriptionally
competent muscle specific gene domain and that
H3K4me2 and H3K4me3 mark the LCR in different distri-
butions. In addition, H3K27me3 may contribute to the
silencing of tissue-specific methylation-free CpG islands
in non-expressing tissues. These observations provide
insight into the important elements such as HS3 within
the DES LCR and highlight the significance of also inves-
tigating the underlying DNA methylation pattern when
examining chromatin structure at any given gene locus.
Histone H3 lysine (K) 27 tri-methylation (me3) is highly enriched at the DES CpG island in non-expressing PBMCs Figure 4
Histone H3 lysine (K) 27 tri-methylation (me3) is highly enriched at the DES CpG island in non-expressing 
PBMCs. nChIP experiments (Figure 2) were performed using antibodies against H3K27me3. (A) H3K27me3 of DES and the 
DES LCR in non-expressing PBMCs (grey bars). Non-specific binding was assessed by employing IgG (dark grey bars) and no 
antibody (stripped bars) samples as controls. Results are presented as fold-enrichment of IP samples over input DNA. Error 
bars represent the standard deviation about the mean fold-enrichment from at least 2 separate PCRs performed in duplicate 
from 2 independent nChIP experiments. (B) Illustration of DES and the DES LCR. Vertical arrows indicate the regions of high 
sequence conservation within each HS site of the LCR and the DES transcriptional start site (TSS) is represented by a horizon-
tal arrow. Black rectangles denote the exons of DES. PCR amplicons (A-J) are shown by vertical black bars. Significant 
H3K27me3 enrichment was seen only at the DES promoter/CpG island.
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Methods
Mammalian Cell culture
Adult human primary myoblast cells were a generous gift
from Serge Braun, Association Française contre les Myopa-
thies, Evry, France (formerly at Transgene SA, Strasbourg,
France) and were isolated from a skeletal muscle biopsy
obtained after informed consent and in accordance with
local French regulatory approval from a healthy 14 year
old Caucasian male. These myoblast cells were cultured in
Dulbecco's modified eagles medium (DMEM) supple-
mented with 10% fetal calf serum (FCS), 2% Ultroser® G
(Pall BioSepra, Cergy, France), 5 ml penicillin/streptomy-
cin (pen/strep100 μg/ml) and 5 ml glutamine. To obtain
fused myotubes, myoblasts were grown to confluency and
transferred to fusion media consisting of DMEM, 10%
FCS, 5 ml pen/strep (100 μg/ml), and 5 ml glutamine.
Whole blood samples were obtained by informed consent
from normal healthy human volunteers in accordance
with King's College London Ethical Committee guidelines
and procedures. Whole blood was cultured for 72 hrs in
500 ml of RPMI (Roswell Park Memorial Institute) 1640,
5 ml 1 mg/ml Phaseolus Vulgaris Phytohemagglutinin (PHA-
P 1 mg/ml, St. Louis, MO, USA), 5 ml pen/strep (100 μg/
ml) and 5 ml glutamine. Peripheral blood mononuclear
cells (PBMCs) were then isolated after lysis of red blood
cells with RBC lysis buffer (0.1 mM EDTA, 155 mM
NH4Cl, 10 mM KHCO3).
Native Chromatin Immunoprecipitation (nChIP)
nChIP experiments were performed at least twice using
polynucleosomes from independently prepared chroma-
tin preparations as previously described [30]. Both ChIP-
on-chip and Q-PCR was conducted on the same input
material. ChIP analysis for various histone modifications
were conducted as before [30]. Equivalent amounts of
recovered nChIP input and immunoprecipitated (IP)
DNA were analysed by quantitative real-time PCR (Q-
PCR) using the QuantiTect SYBR Green PCR Master Mix
(Qiagen, Crawley, UK) system on a LightCycler™ 1.2
(Roche Applied Science, Lewes, UK) as described [40].
Primers used for PCR amplification are shown in Addi-
tional file 1, Table ST1. A melting curve program was per-
formed and showed that all PCR primers were specific for
the target sequences (Additional data file 1, Figures S4B
and B'). Fold enrichment of selected regions of DNA
within IP samples was calculated by subtracting the IP Ct
(cycle threshold) value from the input Ct value and was
presented as a ratio of 2-CtIP to 2-Ct input [30,40]. All primers
were optimized to amplify the same amount of DNA with
equivalent efficiency (Additional data file 1, Figures S4C
and C').
Antibodies
The following antibodies were used: 20 μg of anti-Histone
H3 acetylation lysines (K) 9 and 14 (Millipore #06–599;
Billerica, MA, USA), 50 μl of anti-Histone H4 acetylation
lysines (K) 4,7,11 and 14 (Millipore, #06–866), 50 μl of
anti-Histone H3 dimethyl Lysine 4 (H3K4me2; Millipore,
#07–030), 50 μl of anti-Histone H3 trimethyl Lysine 4
(H3K4me3; Millipore, #07–473) and 20 μl of anti-His-
tone H3 trimethyl Lysine 27 (H3K27me3: Millipore, #07–
449).
ChIP-on-chip analysis
A high resolution DNA microarray was constructed across
500 kb of chromosome 2 using 500 bp overlapping PCR
products as previously described [41]. Briefly, primer pairs
were designed using the Primer3 software and Web site
with Repeat Masking. All primers had a universal amino-
linked tag sequence (5'-TGACCATG-3') attached to the 5'
end of the sense strand primer, to allow covalent binding
to the microarray slide. PCR reactions were conducted on
a Flexigene Techne PCR machine using BAC clone acces-
sion number AC053503 DNA as a template which encom-
passes the DES locus and surrounding regions. DNA was
denatured at 94°C for five minutes followed by 30 cycles
of 94°C for 30 seconds, 65°C for 30 seconds and 72°C
for 60 seconds. A final extension step at 72°C for five min-
utes was performed. A 5 μl aliquot of the reaction was run
on a 2.5% agarose gel to confirm product specificity.
Amino-liked specific PCR products were spotted onto the
glass array slides in duplicate by the microarray facility at
the Wellcome Trust Sanger Institute, Hinxton, Cambridge.
Approximately 300 ng of nChIP DNA sample, input and
IP were labelled using Cy-5 and Cy-3 dye modified dCTP
respectively. These samples were pooled precipitated with
human Cot-1 DNA (Roche Applied Sciences, Lewes, UK)
and resuspended in 100 μl of hybridization buffer (10 ml
20×SSC, 50 ml deionised formamide, 10 ml 100 mM Tris-
HCl pH 7.4, 5 g dextran sulphate, 100 μl TWEEN 20) and
left at 65°C to allow the labelled DNA pellets to dissolve.
The samples were loaded onto the microarray slides in the
Tecan HS 400™ Pro hybridization machine (Tecan Group
Ltd., San Jose, USA) for a 72 hour hybridization reaction
which included subsequent washing steps.
Hybridised microarray slides were scanned on an Axon
4000B scanner (Molecular Devices, Concord, Canada).
The photon multiplier tube (PMT) levels used for detec-
tion were adjusted and tailored for each individual array.
Arrays were analysed using Genepix 4.0. Software (Molec-
ular Devices, Concord, Canada). Single image TIFF files
from Genepix 4.0 were imported into the 'Spot' program
for analysis [42]. The spot file was then uploaded into a
custom made Excel based macro, which gave average
enrichment ratios for each region represented on the
array. The DNA chip data was normalized over the entire
microarray which not only contained the ENr331 region
but also other ENCODE areas under investigation, specif-BMC Molecular Biology 2009, 10:51 http://www.biomedcentral.com/1471-2199/10/51
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ically loci from chromosomes 10, 11 14, 16 and X. The
array also had smaller tiles from chromosomes 2, 5, 7 and
9. This allows accurate comparison of the histone modifi-
cation patterns between different cell types. Even though
diverse patterns of histone modifications can be com-
pared between different ChIP samples, absolute levels of
histone H3 and H4 acetylation cannot be evaluated as
antibody affinities will vary [43]. The ChIP-on-chip exper-
iment was conducted in duplicate for each spot on the
array and repeated with an independent biological sam-
ple. The average ratio for each set of duplicates was then
calculated and the mean was taken between independent
experiments.
DNA bisulphite conversion and sequencing
Total genomic DNA (2 μg) from myoblasts, myotubes
and PBMCs, was digested with 5 μl HindIII (100 units)
and 5 μl 10× buffer in a reaction volume of 50 μl for 3 hrs
at 37°C. The digested DNA was then denatured by adding
3 M NaOH to a final concentration of 0.3 M and incu-
bated at 37°C for 15–20 min. The denatured DNA was
added to 1.1 ml of pre-warmed freshly prepared sodium
bisulphite solution (4.5 M sodium bisulphite, 2.5 mM
hydroquinone, 0.225 M NaOH, pH5), covered with 200
μl of mineral oil and incubated for 5 hrs at 55°C in the
dark. The bisulphite treated DNA was purified using the
QiaexII gel extraction kit (Qiagen). The sample was then
desulphonated by adding 3 M NaOH to a final concentra-
tion of 0.3 M and incubated at 37°C for 15–20 min. The
sample was then neutralized by adding 6 M ammonium
acetate to a final concentration of 3 M and DNA precipi-
tated by adding 3 volumes of 100% ice-cold ethanol. PCR
amplification of selected regions with nested pairs of
primers (see Additional file 1, Table ST1) was carried out
on the bisulphite converted DNA using the same condi-
tions as above but for 35 cycles. PCR products were cloned
into the pCR 2.1 TOPO vector (Invitrogen, Paisley, UK)
and sequenced using M13 forward and reverse primers.
Abbreviations
DES: human desmin gene; LCR: locus control region;
ENCODE: Encyclopaedia Of DNA Elements; HS: DNaseI
hypersensitive site; H3K4me2: H3 lysine 4 di-methyla-
tion; TSS: transcriptional start site; H3K27me3: H3 lysine
27 tri-methylation; PBMCs: peripheral blood mononu-
clear cells; nChIP: native chromatin immunoprecipita-
tion; UF: unfused myoblasts and F-fused mytoubes; TF:
transcription factor; PcG: Polycomb Group.
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